4 minute read
Infantile Colic
Other useful information sources you can offer to parents.
Cry-sis - the only UK charity offering help and support to parents with babies who cry excessively or have sleeping problems - https://www.cry-sis.org.uk/
NHS - https://www.nhs.uk/conditions/ colic/
Article sponsored by:
offering babies and easy and convenient way to feed at their own pace.
Explanation as to how a Dr Brown’s Options™ bottle works?
Parents can see a fully animated explanation on www.drbrowns.co.uk
Dr Brown’s is the most recommended baby bottle for the relief of wind related colic*.
When can parents expect their baby to stop suffering from Colic?
Thankfully babies tend to grow out of Colic between four and six months, as baby’s feeding become more developed.
Dr Brown’s availability:
Dr Brown’s Options bottles and feeding accessories are available for pharmacies to purchase from http://www.murrayshealthandbeauty.com/
References: Results from a HCP Colic Survey carried out by Consumer Analysis – May 2010 and research conducted by Mustard Research Ltd amongst a sample of 200 UK Health Care Professionals during May 2017.
Aspirin 250mg, Paracetamol 250mg, Ca eine 65mg film-coated Tablets
UNIQUE TRIPLE ACTION COMBINATION
Starts relieving Migraine Pain & Symptoms in 30 minutes1
CONTAINS PARACETAMOL. ALWAYS READ THE LABEL / LEAFLET
Product Information: Please consult the summary of product characteristics for full Product Information. Excedrin 250 mg/250 mg/65 mg film coated tablets (acetylsalicyclic acid, paracetamol, caffeine). Indications: Acute treatment of headache and of migraine attacks with or without aura. Dosage: Maximum 6 tablets in 24 hours. Drink a full glass of water with each dose. Must not be used for a longer period or at a higher dosage without rst consulting a doctor. Not for use in those under 18 years. Exercise caution in the elderly. Headache: 1 tablet; if needed an additional tablet can be taken. In case of more intense pain, 2 tablets. If needed, an additional 2 tablets can be taken. Allow 4 to 6 hours between doses. For episodic use, up to 4 days. Migraine: 2 tablets when symptoms appear. If needed, an additional 2 tablets can be taken, with 4 to 6 hours between doses. For episodic use, up to 3 days. Contraindications: Hypersensitivity to ingredients. Patients in whom attacks of asthma, urticaria, or acute rhinitis are precipitated by aspirin or other NSAIDs, e.g. diclofenac or ibuprofen. Active gastric or intestinal ulcer, gastrointestinal bleeding or perforation and in patients with a history of peptic ulceration. Haemophilia or other haemorrhagic disorders. Severe cardiac, hepatic or renal failure. Intake of >15 mg methotrexate per week. Third trimester of pregnancy. Warnings and precautions: Not to be taken with other products containing aspirin or paracetamol. Not to be used if vomiting occurs with >20% or bedrest is needed with >50% of migraine attacks. Seek medical advice if no migraine relief from rst 2-tablet dose. Not to be used on >10 days per month for >3 months. Discontinue use in actual or suspected medication overuse headache; gastrointestinal bleeds or ulceration. Risk of bleeding could be enhanced by alcohol, NSAIDs and corticosteroids. Caution in undiagnosed migraineurs, or those with atypical symptoms, exclude other neurological conditions; patients with dehydration, gout, impaired renal or hepatic function, uncontrolled hypertension, diabetes mellitus, severe glucose 6-phosphate dehydrogenase de ciency, alcohol dependence, hyperthyroidism, arrhythmia, bronchial asthma, seasonal allergic rhinitis, nasal polyps, chronic obstructive pulmonary disease, chronic infection of the respiratory tract, patients showing allergic reactions to other substances (e.g. cutaneous reactions, urticaria). May mask signs and symptoms of infection, increase bleeding tendency during/after surgery. Not to be taken with anticoagulant or other medicines that inhibit platelet aggregation unless under doctor supervision. Monitor in patients with defects of haemostasis. Caution in case of metrorrhagia or menorrhagia. May interfere with thyroid function tests. Caution in those taking liver enzyme inducers or potentially hepatotoxic medicines, or alcohol. Limit intake of caffeine-containing products. Pregnancy and lactation: Contraindicated in third trimester. Caution in 1st and 2nd trimester. Not recommended during breastfeeding. Side effects: Common: Nervousness, dizziness, nausea, abdominal discomfort. Uncommon: Insomnia, tremor, paraesthesia, headache, tinnitus, arrhythmia, dry mouth, diarrhoea, vomiting, fatigue, feeling jittery. Rare: Pharyngitis, decreased appetite, anxiety, euphoric mood, tension, dysgeusia, disturbance in attention, amnesia, coordination abnormal, hyperaesthesia, sinus headache, eye pain, visual disturbance, ushing, peripheral vascular disorder, epistaxis, hypoventilation, rhinorrhoea, eructation, atulence, dysphagia, paraesthesia oral, salivary hypersecretion, hyperhidrosis, pruritus, urticaria, musculoskeletal stiffness, neck and back pain, muscle spasms, asthenia, chest discomfort. Not known: Hypersensitivity, anaphylactic reaction, Stevens Johnson syndrome, toxic epidermal necrolysis, restlessness, migraine, somnolence, palpitations, hypotension, dyspnoea, asthma, abdominal pain, dyspepsia, GI haemorrhage, GI ulcer, hepatic failure, hepatic enzyme increased, erythema, rash, angioedema, malaise, feeling abnormal. See SPC for full details. Legal category: Pharmacy only. MA number: PA 678/122/1. MA holder: GlaxoSmithKline Consumer Healthcare (Ireland) Limited. 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland. Text revised: September 2017. Further information available on request. Reference 1: Lipton R et al. Ef cacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double blind, randomized, placebo-controlled trials. Arch Neurol. 1998;55:210-217.
